Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis
- 1 September 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 11 (9) , 1295-1303
Abstract
(2011). Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis. Expert Review of Neurotherapeutics: Vol. 11, No. 9, pp. 1295-1303.Keywords
This publication has 80 references indexed in Scilit:
- Mesenchymal stem cells and autoimmune diseasesBest Practice & Research Clinical Haematology, 2011
- Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter?Current Stem Cell Research & Therapy, 2011
- Inhibition of Immune Synapse by Altered Dendritic Cell Actin Distribution: A New Pathway of Mesenchymal Stem Cell Immune RegulationThe Journal of Immunology, 2010
- Fetal BM‐derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cellsEuropean Journal of Immunology, 2009
- Adipose-Derived Mesenchymal Stem Cells Ameliorate Chronic Experimental Autoimmune EncephalomyelitisStem Cells, 2009
- Reciprocal Interactions Between Human Mesenchymal Stem Cells and γδ T Cells Or Invariant Natural Killer T CellsStem Cells, 2009
- The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapseBMC Genomics, 2007
- Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cellsBlood, 2006
- Human mesenchymal stem cells modulate allogeneic immune cell responsesBlood, 2005
- Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivoExperimental Hematology, 2002